Difference between revisions of "NM Coordinating Committee"
Jump to navigation
Jump to search
Line 7: | Line 7: | ||
==Scope== | ==Scope== | ||
− | The NM Coordinating Committee | + | The NM Coordinating Committee is responsible for: |
+ | :* Monitoring and coordinating the activities of NM Biomarker Committees | ||
+ | ::* [https://docs.google.com/spreadsheets/d/1A7_uieyw0uu2DKbP6Vkzd37JuBEb2zmm-yqfXJtV-p4/edit?usp=sharing QIBA Profile Dashboard] (NM Page) | ||
:* Considering and proposing new candidate Biomarker Committees to the [[Steering Committee]] | :* Considering and proposing new candidate Biomarker Committees to the [[Steering Committee]] | ||
:* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee | :* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee |
Revision as of 18:43, 1 June 2021
Co-Chairs: P. David Mozley, MD; Anne Smith, PhD; John J.Sunderland, PhD
RSNA Staff Support: Julie Lisiecki
Scope
The NM Coordinating Committee is responsible for:
- Monitoring and coordinating the activities of NM Biomarker Committees
- QIBA Profile Dashboard (NM Page)
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
- FDG-PET_Biomarker_Ctte
- PET_Amyloid_Biomarker_Ctte
- SPECT_Biomarker_Ctte
- TC99m Biomarker Committee [page coming soon]
- I-123 Biomarker Committee [page coming soon]
Meetings
- WebEx calls are held Quarterly. Please contact RSNA Staff for details.